Medical control of IOP after cataract surgery.
Chakraborty
P
P
Villada
J R
JR
Tinu
A
A
D000086:Acetazolamide / Q000627:therapeutic use*; D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use*; D002257:Carbonic Anhydrase Inhibitors / Q000627:therapeutic use*; D003000:Clonidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects*; D009798:Ocular Hypertension / Q000209:etiology / Q000517:prevention & control*; D018918:Phacoemulsification / Q000009:adverse effects
D000316:Adrenergic alpha-Agonists; D002257:Carbonic Anhydrase Inhibitors; C016986:apraclonidine; D003000:Clonidine; D000086:Acetazolamide